Abivax SA ADR (2X10)
XSTU
Real-time Data
06:00 AM
Day's Range
98.0052 wk Range
61.50Overview - 2X10 - Abivax SA ADR
Key Statistics
Valuation
Enterprise Value
7.35B
P/E (Trailing)
‪-20.91‬
PEG Ratio
‪0.78‬
Price / Sales (TTM)
‪1,746.84‬
Price / Book
‪18.18‬
EV / EBITDA
‪-28.94‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-4,183.70%‬
Return on Assets
‪-44.65%‬
Return on Equity
‪-157.06%‬
Ownership
Shares Outstanding
79.29M
Float
69.35M
Held by Insiders
‪0.00%‬
Held by Institutions
‪76.81%‬
Price stats
Beta
‪-0.22‬
50-Day Avg
‪106.40‬
200-Day Avg
‪102.81‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 2X10 - Abivax SA ADR
Peers - 2X10 - Abivax SA ADR
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 2X10XSTUAbivax SA ADR8.72BMarket Cap+35.02%52-week change-20.39P/E (Trailing)‪0.00%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+5.19%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech Inc.8.74BMarket Cap+57.88%52-week change44.81P/E (Trailing)‪54.81%‬Profit Margin
- 19XXSTUAxsome Therapeutics, Inc.7.98BMarket Cap+41.14%52-week change-47.55P/E (Trailing)‪92.56%‬Profit Margin
- 30JXSTUIdeaya Biosciences Inc.3.25BMarket Cap+33.59%52-week change-26.12P/E (Trailing)‪-74.75%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+65.30%52-week change-107.13P/E (Trailing)—Profit Margin
- BSFAXSTUAni Pharmaceuticals Inc.1.45BMarket Cap-21.26%52-week change16.28P/E (Trailing)‪11.07%‬Profit Margin
Profile Summary - 2X10 - Abivax SA ADR
About
Abivax S.A. American Depositary Receipt represents shares in Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms, particularly through enhanced expression of microRNA-124, to stabilize the immune response in patients with chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
